<?xml version="1.0" encoding="utf-8"?>
<journal>
<title>Medical Journal of the Islamic Republic Of Iran</title>
<title_fa>مجله پزشکی جمهوری اسلامی ایران</title_fa>
<short_title>Med J Islam Repub Iran</short_title>
<subject>Medical Sciences</subject>
<web_url>http://mjiri.iums.ac.ir</web_url>
<journal_hbi_system_id>2</journal_hbi_system_id>
<journal_hbi_system_user>journal2</journal_hbi_system_user>
<journal_id_issn>1016-1430</journal_id_issn>
<journal_id_issn_online>2251-6840</journal_id_issn_online>
<journal_id_pii>8</journal_id_pii>
<journal_id_doi>10.18869/mjiri</journal_id_doi>
<journal_id_iranmedex></journal_id_iranmedex>
<journal_id_magiran></journal_id_magiran>
<journal_id_sid>14</journal_id_sid>
<journal_id_nlai>8888</journal_id_nlai>
<journal_id_science>13</journal_id_science>
<language>en</language>
<pubdate>
	<type>jalali</type>
	<year>1381</year>
	<month>8</month>
	<day>1</day>
</pubdate>
<pubdate>
	<type>gregorian</type>
	<year>2002</year>
	<month>11</month>
	<day>1</day>
</pubdate>
<volume>16</volume>
<number>3</number>
<publish_type>online</publish_type>
<publish_edition>1</publish_edition>
<article_type>fulltext</article_type>
<articleset>
	<article>


	<language>en</language>
	<article_id_doi></article_id_doi>
	<title_fa></title_fa>
	<title>A SURVEY OF CELLULAR IMMUNITY, TOTAL T-LYMPHOCYTE, T-ACTIVE , B-LYMPHOCYTE A ND T-CELL FUNCTION IN RELATION TO PHYTOHEMAGGLUTININ (PHA) IN THALASSEMIC PATIENTS</title>
	<subject_fa></subject_fa>
	<subject></subject>
	<content_type_fa>Original Research: Basic Science in Medicine</content_type_fa>
	<content_type>Original Research: Basic Science in Medicine</content_type>
	<abstract_fa></abstract_fa>
	<abstract>The aim of this study was to evaluate the immune system and lymphocyte
function in 41 Iranian β-thalassemic patients and 50 controls, ages ranging
from 2 to 18 years. The patients consisted of 20 splenectomized and 21
non-splenectomized patients. They were treated with Desferal, and had received
repeated blood transfusion. Laboratory investigations included measurement
of total T lymphocytes, active T lymphocytes, B-Iymphocytes and
function of lymphocytes treated with PHA. In this study we observed a significant
reduction of active T lymphocytes and total T lymphocytes in the
patient group compared to controls (p&lt;0.005 &amp; p&lt;0.001), but there was no
significant difference between splenectomized and non-splenectomized patients.
Also in both groups, lymphocyte function was reduced against PHA
(phytohemagglutinin) compared with the controls, and the numbers of B cells
were increased. These results lead to the conclusion that the deficient immune
system in β-thalassemia causes infectious diseases, which finally leads
to death. Therefore, stimulation of the immune system as well as clinical treatment
may prevent infectious disease in patients with β- thalassemia.
</abstract>
	<keyword_fa></keyword_fa>
	<keyword>Thalassemic patient, Immune system, Cytomegalovirus, Blood transfusion.</keyword>
	<start_page>169</start_page>
	<end_page>172</end_page>
	<web_url>http://mjiri.iums.ac.ir/browse.php?a_code=A-10-298-205&amp;slc_lang=en&amp;sid=1</web_url>


<author_list>
	<author>
	<first_name>T</first_name>
	<middle_name></middle_name>
	<last_name>ZANDIEH</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email>TZ7892000@Yahoo.com</email>
	<code>20031947532846003969</code>
	<orcid>20031947532846003969</orcid>
	<coreauthor>Yes
</coreauthor>
	<affiliation>From the Iranian Blood Transfusion Service, Tehran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>F</first_name>
	<middle_name></middle_name>
	<last_name>TARABADI</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846003970</code>
	<orcid>20031947532846003970</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>From the Iranian Blood Transfusion Service, Tehran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>A</first_name>
	<middle_name></middle_name>
	<last_name>TABATABAIYAN</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846003971</code>
	<orcid>20031947532846003971</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>From the Iranian Blood Transfusion Service, Tehran</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


	<author>
	<first_name>M</first_name>
	<middle_name></middle_name>
	<last_name>IZADYAR</last_name>
	<suffix></suffix>
	<first_name_fa></first_name_fa>
	<middle_name_fa></middle_name_fa>
	<last_name_fa></last_name_fa>
	<suffix_fa></suffix_fa>
	<email></email>
	<code>20031947532846003972</code>
	<orcid>20031947532846003972</orcid>
	<coreauthor>No</coreauthor>
	<affiliation>the Department of Hematology, Pediatric Medical Center, Tehran University of Medical Sciences, Tehran, I.R. Iran.</affiliation>
	<affiliation_fa></affiliation_fa>
	 </author>


</author_list>


	</article>
</articleset>
</journal>
